Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study

OBJECTIVE: The aim of this study is to determine the safety and the efficacy of amifampridine phosphate in muscle-specific kinase antibody-positive myasthenia gravis, in a 1:1 randomized, double-blind, placebo-controlled, switchback, double crossover study. METHODS: Eligible patients had muscle-spec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:SAGE Open Med
Main Authors: Bonanno, Silvia, Pasanisi, Maria Barbara, Frangiamore, Rita, Maggi, Lorenzo, Antozzi, Carlo, Andreetta, Francesca, Campanella, Angela, Brenna, Greta, Cottini, Lorenzo, Mantegazza, Renato
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299310/
https://ncbi.nlm.nih.gov/pubmed/30574306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312118819013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados